CSL: Our position on AZ-Oxford has not changed

This is a preview of subscriber content

Subscribe now to continue reading.

They restated the company's part in ongoing discussions with AstraZeneca and the government, highlighting the myriad of complexities, including regulatory. They said the company will provide an update when it has one and that it is cognizant of the responsibility to manage the expectations of shareholders and the wider community. …

Subscribe now to continue reading.

CSL: Our position on AZ-Oxford has not changed

This is a preview of subscriber content

Latest Video

Most Read

Surely this therapy is an example of our system at its absolute worst?

A comment that highlights how complexity is making the challenge more challenging

Two new listings add treatment choices for growth hormone deficiency and people with type 1 diabetes

Officials highlight benefits but urge caution in rollout of AI-driven medical scribes

When it comes to negotiating with government, trust actions and not words

New Stories

Nasal adrenaline to be added to the PBS for people at risk of anaphylaxis

When it comes to negotiating with government, trust actions and not words

Neuren partner secures critical European backing for Rett syndrome therapy

Disappointment for CSL as Europe recommends reversing approval of therapy

Ipsen therapy approved in Australia for rare genetic disorder

New MSD vaccine listed on national program with expanded eligibility

A comment that highlights how complexity is making the challenge more challenging

Sign In

CSL: Our position on AZ-Oxford has not changed

This is a preview of subscriber content

Latest Video

Most Read

Surely this therapy is an example of our system at its absolute worst?

A comment that highlights how complexity is making the challenge more challenging

Two new listings add treatment choices for growth hormone deficiency and people with type 1 diabetes

Officials highlight benefits but urge caution in rollout of AI-driven medical scribes

When it comes to negotiating with government, trust actions and not words

Follow Us

New Stories

Nasal adrenaline to be added to the PBS for people at risk of anaphylaxis

When it comes to negotiating with government, trust actions and not words

Neuren partner secures critical European backing for Rett syndrome therapy

Disappointment for CSL as Europe recommends reversing approval of therapy

Ipsen therapy approved in Australia for rare genetic disorder

New MSD vaccine listed on national program with expanded eligibility

A comment that highlights how complexity is making the challenge more challenging